Funding opportunity: Advancing innovation in accelerated cancer diagnosis
Ref: GRT-M40S2UEW
Funding Available
Up to £25,400,000
UK Wide
Life Sciences & Health
28 October 2026
Grants & Funding
About This Grant
Innovate UK, on behalf of the OLS Cancer Healthcare Goals programme, will invest up to £25.4 million to support the clinical validation and evaluation of early cancer diagnostic technologies and devices.
What Can It Fund?
- Clinical validation
- evaluation of early cancer diagnostic technologies and devices
Funding Source
Innovate UK / Office for Life Sciences (OLS)
Explore More
Similar Grants
Chemical, biological, radiological and nuclear (CBRN) medical countermeasures R&D
Apply for funding to develop and test novel therapeutics, medical devices, diagnostics and other interventions across any stage of the developmental pathway, from prototype development, through pre-clinical refinement, to early-phase clinical studies (up to phase 2a) for CBRN threats. Applications must demonstrate how the proposed research will result in improved domestic preparedness for CBRN threats.
Invite only: Precision prevention: biological mechanisms of response variation
Apply for funding to investigate why biomedical prevention interventions work differently across people. Projects must generate mechanistic evidence in humans by testing biomedical experimental interventions or challenges in pre-disease or early disease states, providing insight into how to improve the targeting and effectiveness of precision prevention strategies.
Water4All 2026 call: sustainable water management
Funding for UK-based researchers to collaborate with international partners and submit joint applications for sustainable water management research.